[{"Assets_0_FY_USD":1574802000.0,"CommonStockSharesOutstanding_0_FY_shares":101177007.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-562616000.0,"NetIncomeLoss_1_FY_USD":-211441000.0,"NetIncomeLoss_4_FY_USD":-761497000.0,"StockholdersEquity_0_FY_USD":1301965000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190214"}]